BlackRock’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,629,605
| Closed | -$73.7M | – | 6098 |
|
|
2022
Q1 | $73.7M | Sell |
2,629,605
-8,728
| -0.3% | -$239K | ﹤0.01% | 2332 |
|
|
2021
Q4 | $72.1M | Buy |
2,638,333
+44,498
| +2% | +$1.21M | ﹤0.01% | 2421 |
|
|
2021
Q3 | $70.6M | Sell |
2,593,835
-362,503
| -12% | -$8.96M | ﹤0.01% | 2425 |
|
|
2021
Q2 | $50.5M | Sell |
2,956,338
-18,824
| -0.6% | -$352K | ﹤0.01% | 2696 |
|
|
2021
Q1 | $62.1M | Buy |
2,975,162
+89,386
| +3% | +$2.06M | ﹤0.01% | 2482 |
|
|
2020
Q4 | $66.1M | Buy |
2,885,776
+235,862
| +9% | +$4.49M | ﹤0.01% | 2307 |
|
|
2020
Q3 | $43.2M | Sell |
2,649,914
-68,156
| -3% | -$1.23M | ﹤0.01% | 2383 |
|
|
2020
Q2 | $36.8M | Buy |
2,718,070
+123,355
| +5% | +$1.44M | ﹤0.01% | 2427 |
|
|
2020
Q1 | $30.7M | Sell |
2,594,715
-54,015
| -2% | -$1.2M | ﹤0.01% | 2363 |
|
|
2019
Q4 | $66M | Buy |
2,648,730
+190,196
| +8% | +$3.85M | ﹤0.01% | 2196 |
|
|
2019
Q3 | $41.8M | Buy |
2,458,534
+78,100
| +3% | +$1.42M | ﹤0.01% | 2403 |
|
|
2019
Q2 | $54.2M | Sell |
2,380,434
-3,248
| -0.1% | -$87.6K | ﹤0.01% | 2274 |
|
|
2019
Q1 | $76.6M | Sell |
2,383,682
-77,404
| -3% | -$2.4M | ﹤0.01% | 2040 |
|
|
2018
Q4 | $69.4M | Sell |
2,461,086
-145,997
| -6% | -$4.28M | ﹤0.01% | 2039 |
|
|
2018
Q3 | $75M | Buy |
2,607,083
+296,973
| +13% | +$8.92M | ﹤0.01% | 2156 |
|
|
2018
Q2 | $86.5M | Buy |
2,310,110
+371,831
| +19% | +$14.6M | ﹤0.01% | 2041 |
|
|
2018
Q1 | $76.2M | Sell |
1,938,279
-42,663
| -2% | -$1.56M | ﹤0.01% | 2017 |
|
|
2017
Q4 | $64.2M | Buy |
1,980,942
+39,761
| +2% | +$1.19M | ﹤0.01% | 2131 |
|
|
2017
Q3 | $60.5M | Sell |
1,941,181
-3,732
| -0.2% | -$110K | ﹤0.01% | 2169 |
|
|
2017
Q2 | $54.4M | Buy |
1,944,913
+300,920
| +18% | +$6.81M | ﹤0.01% | 2197 |
|
|
2017
Q1 | $28.2M | Buy |
1,643,993
+1,641,917
| +79,090% | +$23M | ﹤0.01% | 2558 |
|
|
2016
Q4 | $25K | Sell |
2,076
-7,245
| -78% | -$93.8K | ﹤0.01% | 3195 |
|
|
2016
Q3 | $147K | Sell |
9,321
-3,699
| -28% | -$55.7K | ﹤0.01% | 2360 |
|
|
2016
Q2 | $168K | Buy |
13,020
+12,010
| +1,189% | +$188K | ﹤0.01% | 2207 |
|
|
2016
Q1 | $19K | Sell |
1,010
-229
| -18% | -$4.15K | ﹤0.01% | 2886 |
|
|
2015
Q4 | $28K | Buy |
1,239
+900
| +265% | +$17.8K | ﹤0.01% | 2401 |
|
|
2015
Q3 | $8K | Hold |
339
| – | – | ﹤0.01% | 2852 |
|
|
2015
Q2 | $10K | Buy |
+339
| New | +$8.88K | ﹤0.01% | 2813 |
|
BlackRock's XENT Position: Q2 2022 in Review
BlackRock sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 2,629,605 shares — an estimated $73.7M sold.
BlackRock first reported a position in XENT in Q2 2015 and held it in 28 quarters. The position peaked at $86.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- BlackRock reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- BlackRock sold 2,629,605 Intersect ENT, Inc shares in Q2 2022, an estimated $73.7M.
- BlackRock first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 28 quarters.
- BlackRock's Intersect ENT, Inc position peaked at $86.5M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.